Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1743studies shown
Showing 241-252 of 1,743
Drug study icon
TerminatedEUCTR 2019-002640-25

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF SAGE-217 WITH FIXED, REPEATED TREATMENT REGIMEN ON RELAPSE PREVENTION IN ADULTS WITH MAJOR DEPRESSIVE DIS...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
DepressionDrugA study involving a medication or substance.
Countries
United Kingdom, Denmark, Spain
Sponsor
Sage Therapeutics, Inc.
Condition
Depression
Drug study icon
CompletedEUCTR 2009-011745-94

A Phase 3b, Double-blind, Randomised, Active-controlled, Parallel-group Study to Compare the Time to Response of Lisdexamfetamine Dimesylate to Atomoxetine Hydrochloride in Children and Adolescents...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
ADHDDrug
Countries
France, United Kingdom, Belgium, ...
Sponsor
Shire Pharmaceutical Development Limited
Condition
ADHD
Drug study icon
CompletedEUCTR 2010-020951-30

A Phase 4, Open-label, Multicentre, 2-Year Safety Study of Lisdexamfetamine Dimesylate in Children and Adolescents Aged 6-17 Years with Attention-Deficit/Hyperactivity Disorder (ADHD)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
ADHDDrug
Countries
United Kingdom, Belgium, Germany, ...
Sponsor
Shire Pharmaceutical Development Ltd
Condition
ADHD
Drug study icon
CompletedEUCTR 2015-000222-11

A phase II, randomised, double-blind, placebo- controlled, multi-site, parallel group clinical trial to examine ketamine as a pharmacological treatment for alcohol dependence in an alcohol dependen...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
AddictionDrug
Countries
United Kingdom
Sponsor
University College London
Condition
Addiction
Drug study icon
TerminatedEUCTR 2013-000361-36

A phase IIa/b, randomised, double-blind, placebo-controlled, single-site, parallel group clinical trial to examine cannabidiol (CBD) as a pharmacological treatment for cannabis dependence in a youn...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
AddictionDrug
Countries
United Kingdom
Sponsor
Joint Research Office
Condition
Addiction
Drug study icon
CompletedEUCTR 2008-000720-10

A Phase III, Double- Blind, Placebo- Controlled, Randomised Withdrawal, Multicentre, Extension, Safety and Efficacy of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17 with A...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
ADHDDrug
Countries
France, United Kingdom, Belgium, ...
Sponsor
Shire Pharmaceutical Development Limited
Condition
ADHD
Drug study icon
CompletedEUCTR 2008-000679-90

A Phase III, Randomised, Double-Blind, Multicentre, Parallel-Group, Placebo- and Active-Controlled, Dose-Optimisation Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
ADHDDrug
Countries
France, United Kingdom, Belgium, ...
Sponsor
Shire Pharmaceutical Development Limited
Condition
ADHD
Drug study icon
CompletedEUCTR 2015-004210-26

A Phase IV double blind multi-site, individually randomised parallel group controlled trial investigating the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in pati...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
DepressionDrug
Countries
United Kingdom
Sponsor
PRIMENT Clinical Trials Unit, UCL
Condition
Depression
Drug study icon
TerminatedEUCTR 2014-004077-16

A Phase IV randomised controlled trial of the selective serotonin reuptake inhibitor Sertraline versus Cognitive Behavioural Therapy for anxiety symptoms in people with Generalised Anxiety Disorder...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
AnxietyDrug
Countries
United Kingdom
Sponsor
University College London Joint Research Office
Condition
Anxiety
Drug study icon
CompletedEUCTR 2012-000517-37

A pilot study of Concerta XL in adult offenders with ADHD

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
ADHDDrug
Countries
United Kingdom
Sponsor
King's College London [...] 1. King's College London 2. South London and Maudsley NHS Foundation Trust
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.